Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

He noted that during the first Trump administration, Trump tried to convince the FDA to release the COVID vaccine 2 months early -- before the 2-month safety followup had been conducted for the ...

This special feature contains summaries of “important opinions” published in Virginia Lawyers Weekly during the first half of ...